June 24, 2011

Announcements

Lung Cancer Program Exceeds Accrual Expectations

One of my main priorities for 2011 is to increase efficiency in our clinical research operations and to expand the number of patient accruals to clinical trials.  The Lung Cancer Program recently completed a successful audit process and continues to exceed our accrual expectations each month.  They are to be commended for their extraordinary efforts!  

Led by Scott Gettinger, MD, the research team includes

New Flow Cytometer

Yale Cancer Center, with the support of a Yale Class of 1961 gift, has ordered a new Flow Cytometer for the Flow Cytometry Shared Resource/Cell Sorter Core Facility, directed by Dr. Mark Shlomchik.  The new 8-color machine is manufactured by Stratedigm and will expand the Resource's capacity to process samples in an efficient manner with more sensitive and reliable digital analysis and easier software and operation.  It will replace a FACScalibur "legacy" instrument that is nearly 15 years old and could only detect four colors.

Learn More >>

Iris Isufi, MD Recruited to Join the Hematology Program

Iris Isufi, MD will join the faculty at Yale Cancer Center and Smilow Cancer Hospital on July 1 as an Assistant Professor of Hematology.

Hope, Not Fear Conference a Success

Yale Cancer Center and Smilow Cancer Hospital held our annual Hope, Not Fear conference on breast cancer earlier this week on Yale's West Campus.

Development Update   

The Yale Cancer Center Office of Development reports that two YCC members recently received major gifts from individual donors. Two donors gave $350,000 to the Herbst Translational Research Fund.  A third donor made a gift of $125,000 to Dan DiMaio to support research in the Molecular Virology Program.

Smilow Cancer Hospital  

Hepatocellular Carcinoma Clinic

Tamar Taddei, MD, will begin a clinic at Smilow Cancer Hospital for patients with hepatocellular carcinoma (HCC).

Notables  

Facing Our Risk of Cancer Empowered (FORCE),

the nation's only nonprofit organization dedicated to fighting hereditary breast and ovarian cancer, will award Ellen Matloff with a 2011 Spirit of Empowerment Award for Advocacy in recognition of her

Anees Chagpar

was awarded funding to advance research on cancers in women through the NCI Women's Health Activities Committee to support a conference on the

Funding and Award Opportunities

Susan G. Komen for the Cure Promise Grant

Promise Grants are intended to support collaborative, multi-disciplinary research programs that integrate a set of highly synergistic clinical and/or laboratory based research projects to address a critical issue or question in breast cancer research. Programs funded through this grant mechanism are expected to achieve results that would not otherwise be attainable by investigators working independently and should have significant potential to reduce breast cancer incidence and/or mortality within the decade.

Promise Grant funding will support two or three highly collaborative principal investigators and a multidisciplinary investigative team. The investigative team should utilize their combined laboratory, clinical and/or public health expertise to effectively address the proposed research question(s). Promise Grant teams are expected to include breast cancer consumer advocates as active and integrated members of the research program to maximize the potential for translation of the research findings into outcomes that will impact patient care.

While initiation of a clinical trial during the grant term is not required, it is encouraged. However, research programs must include testing of human samples and/or specimens at some point during the grant term.

Pre-application Deadline:

In the News

Seeking Cures, Then and Now

New York Times

article By Nancy Brinker founder of Susan G. Komen for the Cure

Read More >>

AACR Praises New Cigarette Health Warnings as Significant Step Forward 

with comments from Roy S. Herbst, MD, PhD

Read More >>